Written by TOM MURPHY

COVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.

Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed several years ago protecting the technology behind its preventive shot, Spikevax. The company filed patent infringement lawsuits in both U.S. federal court and a German court.

A Pfizer spokeswoman declined to comment, saying the company had not been served with a copy of the litigation.

Moderna and Pfizer’s two-shot vaccines both use mRNA technology to help patients fight the coronavirus.

The mRNA vaccines work by injecting a genetic code for the spike protein that coats the surface of the coronavirus. That code, the mRNA, is encased in a little ball of fat, and instructs the body’s cells to make some harmless spike copies that train the immune system to recognize the real virus.

That approach is radically different than how vaccines have traditionally been made.

Moderna said it started developing its mRNA technology platform in 2010, and that helped the company quickly produce its COVID-19 vaccine after the pandemic arrived in early 2020.

By the end of that year, U.S. regulators had cleared shots from both Pfizer and Moderna for use after clinical research showed that both were highly effective.

Moderna CEO Stephane Bancel said in a prepared statement that the vaccine developer pioneered that technology and invested billions of dollars in creating it.

The company said it believes its rivals’ vaccine infringes on patents Moderna filed between 2010 and 2016.

Moderna said it recognizes the importance of vaccine access and is not seeking to remove Comirnaty from the market. It also is not asking for an injunction to prevent future sales.

 

Photo via AP Photo/David Zalubowski.

 

Related Stories
‹
COVID Vaccine: CDC Expands Booster Rollout, OKs Mixing Shots
Written by LAURAN NEERGAARD and MIKE STOBBE Millions more Americans can get a COVID-19 booster and choose a different company’s vaccine for that next shot, federal health officials said Thursday. Certain people who received Pfizer vaccinations months ago already are eligible for a booster and now the Centers for Disease Control and Prevention says specific […]
WHO Says COVID Boosters Needed, Reversing Previous Call
An expert group convened by the World Health Organization said Tuesday it “strongly supports urgent and broad access” to booster doses, in a reversal of the U.N. agency’s previous insistence that boosters weren’t necessary and contributed to vaccine inequity. In a statement, WHO said its expert group concluded that immunization with authorized COVID-19 vaccines provide […]
Pfizer Opens Study of COVID Shots Updated To Match Omicron
Written by LAURAN NEERGAARD Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the hugely contagious omicron variant. Pfizer and its partner BioNTech announced the study on Tuesday. COVID-19 vaccine-makers have been updating their shots to better match omicron in case global health authorities decide the change is needed. […]
US Expands COVID Boosters to All Adults, Final Hurdle Ahead
Written by LAURAN NEERGAARD and MATTHEW PERRONE U.S. regulators on Friday moved to open up COVID-19 booster shots to all adults, expanding the government’s campaign to shore up protection and get ahead of rising coronavirus cases that may worsen with the holidays. Pfizer and Moderna announced the Food and Drug Administration’s decision after at least […]
FDA Panel Endorses Lower-Dose Moderna COVID Shot for Booster
Written by LAURAN NEERGAARD and MATTHEW PERRONE U.S. health advisers said Thursday that some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus. The panel of advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, adults with other health problems, […]
Next on FDA’s Agenda: Booster Shots of Moderna, J&J Vaccines
Written by LAURAN NEERGAARD and MATTHEW PERRONE With many Americans who got Pfizer vaccinations already rolling up their sleeves for a booster shot, millions of others who received the Moderna or Johnson & Johnson vaccine wait anxiously to learn when it’s their turn. Federal regulators begin tackling that question this week. On Thursday and Friday, […]
Medically At-Risk North Carolinians Can Get Third COVID Shot
Written by BRYAN ANDERSON North Carolina health officials said Monday that medically vulnerable residents with certain health conditions can get an additional dose of COVID-19 vaccine, though some have already had a third Pfizer or Moderna shot after the U.S. Food and Drug Administration approved it last week. The FDA signed off on the additional dose after […]
Sources: US To Recommend COVID Vaccine Boosters at 8 Months
Written by ZEKE MILLER U.S. health experts are expected to recommend COVID-19 vaccine boosters for all Americans, regardless of age, eight months after they received their second dose of the shot, to ensure lasting protection against the coronavirus as the delta variant spreads across the country. Federal health officials have been actively looking at whether […]
US Clears Updated COVID Boosters Targeting Newest Variants
Written by LAURAN NEERGAARD The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common omicron strain. Shots could begin within days. The move by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. The hope […]
Moderna Sues Pfizer Over Patents Behind COVID-19 Vaccine
Written by TOM MURPHY COVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine. Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed several years ago protecting the technology behind its preventive shot, […]
›